Courtesy of modernatx.com
Courtesy of modernatx.com

Moderna has begun testing its coronavirus vaccine on adolescents, the drugmaker announced Thursday as it gears up for U.S distribution upon imminent approval for adult use.

The company said it plans to enroll 3,000 U.S. teenagers and preteens as young as 12 during its trial stages. Each child participant will receive either the coronavirus candidate or a placebo during both vaccinations.

Moderna CEO Stephane Bancel said the company hopes to have data supporting child vaccination in the spring before the 2021 school year starts.

Meanwhile, Pfizer, which has developed along with German partner BioNTech the other vaccine candidate seeking federal approval in the coming days, launched its child testing program in October.

U.S. pediatricians worry they may not know if any of the shots work for young children in time for the next school year, WUSA-TV (Channel 9) reported.

As of Thursday, the U.S. has roughly 15.4 million coronavirus cases and 290,000 deaths — both tops globally — according to a Johns Hopkins University tracker.

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.